đź’¨ Abstract
Monte Rosa Therapeutics Inc. (GLUE) reported a first-quarter profit of $46.9 million, exceeding Wall Street expectations. The company earned 57 cents per share and generated $84.9 million in revenue, surpassing analyst forecasts of a $25.3 million revenue expectation.
Courtesy: wtop.com
Summarized by Einstein Beta 🤖
Suggested
Trump, los aranceles y el futuro del cine global: la tensiĂłn de Hollywood llega al Festival de Cannes -
Lucila Crexell y el rechazo de Ficha Limpia: “Siempre puede haber un cisne negro” -
Eggs are less likely to crack when dropped on their side, according to science -
How many days and votes does it take to elect a pope? History offers some clues -
PHOTO COLLECTION: France VE Day -
Police say 2 students turned themselves in after fatal stabbing outside California high school -
En video: agentes del DHS visitan una docena de restaurantes en DC
World Video Game Hall of Fame inducts Defender, Tamagotchi, GoldenEye 007 and Quake -
Matt Senk, who led Stony Brook’s surprising run to 2012 College World Series, announces retirement -
VĂctor Zimermann: “Es injusto que tengamos que sacar una norma para quienes se enriquecieron ilĂcitamente” -
Powered by MessengerX.io